BRIEF-Biofrontera Announces Data Base Locks For Two Clinical Studies Supporting Key Data And Regulatory Milestones

Reuters01-08

Jan 8 (Reuters) - Biofrontera Inc BFRI.O:

BIOFRONTERA INC. ANNOUNCES DATA BASE LOCKS FOR TWO CLINICAL STUDIES SUPPORTING KEY DATA AND REGULATORY MILESTONES
BIOFRONTERA INC - PLANS TO SUBMIT SNDA TO FDA IN SUMMER 2026
BIOFRONTERA INC - PHASE 2 ACNE STUDY RESULTS TO FDA IN EARLY Q3 2026

Source text: ID:nGNX2CbdbF

Further company coverage: BFRI.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2601398253?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-08 22:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2601398253","market":"nz","top_or_hot":-1,"title":"BRIEF-Biofrontera Announces Data Base Locks For Two Clinical Studies Supporting Key Data And Regulatory Milestones","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Biofrontera Announces Data Base Locks For Two Clinical Studies Supporting Key Data And Regulatory Milestones</title></head><body><p><span>Jan 8 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/BFRI\">Biofrontera Inc</a> <span>BFRI.O</span>:</p><ul><li><p>BIOFRONTERA INC. ANNOUNCES DATA BASE LOCKS FOR TWO CLINICAL STUDIES SUPPORTING KEY DATA AND REGULATORY MILESTONES</p></li><li><p>BIOFRONTERA INC - PLANS TO SUBMIT SNDA TO FDA IN SUMMER 2026</p></li><li><p>BIOFRONTERA INC - PHASE 2 ACNE STUDY RESULTS TO FDA IN EARLY Q3 2026</p></li></ul><p>Source text: <span>ID:nGNX2CbdbF</span></p><p>Further company coverage: <span>BFRI.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Biofrontera Announces Data Base Locks For Two Clinical Studies Supporting Key Data And Regulatory Milestones</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Biofrontera Announces Data Base Locks For Two Clinical Studies Supporting Key Data And Regulatory Milestones\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-08 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Biofrontera Announces Data Base Locks For Two Clinical Studies Supporting Key Data And Regulatory Milestones</title></head><body><p><span>Jan 8 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/BFRI\">Biofrontera Inc</a> <span>BFRI.O</span>:</p><ul><li><p>BIOFRONTERA INC. ANNOUNCES DATA BASE LOCKS FOR TWO CLINICAL STUDIES SUPPORTING KEY DATA AND REGULATORY MILESTONES</p></li><li><p>BIOFRONTERA INC - PLANS TO SUBMIT SNDA TO FDA IN SUMMER 2026</p></li><li><p>BIOFRONTERA INC - PHASE 2 ACNE STUDY RESULTS TO FDA IN EARLY Q3 2026</p></li></ul><p>Source text: <span>ID:nGNX2CbdbF</span></p><p>Further company coverage: <span>BFRI.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nTUA54FNPK:1","article_id":"2601398253","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2601398253","pubTimestamp":1767883218,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Biofrontera Announces Data Base Locks For Two Clinical Studies Supporting Key Data And Regulatory MilestonesJan 8 (Reuters) - Biofrontera Inc BFRI.O:BIOFRONTERA INC. ANNOUNCES DATA BASE LOCKS FO","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","BFRIW":"Biofrontera Inc Warrant","BFRI":"Biofrontera Inc"},"translate_title":"简介-Biofrontera宣布锁定两项支持关键数据和监管里程碑的临床研究的数据库","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BFRIW":0.9,"BFRI":0.9},"content_text":"BRIEF-Biofrontera Announces Data Base Locks For Two Clinical Studies Supporting Key Data And Regulatory MilestonesJan 8 (Reuters) - Biofrontera Inc BFRI.O:BIOFRONTERA INC. ANNOUNCES DATA BASE LOCKS FOR TWO CLINICAL STUDIES SUPPORTING KEY DATA AND REGULATORY MILESTONESBIOFRONTERA INC - PLANS TO SUBMIT SNDA TO FDA IN SUMMER 2026BIOFRONTERA INC - PHASE 2 ACNE STUDY RESULTS TO FDA IN EARLY Q3 2026Source text: ID:nGNX2CbdbFFurther company coverage: BFRI.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2601398253","isCrawlerRequest":true}